ArticleAmbio2025
A governance perspective on agri-environmental schemes: Actors, roles, and barriers.
Article in Ambio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Agri-environmental schemes (AES) carry significant environmental expectations. However, their environmental performance has often been questioned. Existing research has tackled the issue from ecological and economic perspectives. This study aims to provide a complementary governance perspective. It first develops a theoretical framework to analyze AES governance through a multilevel lens, identifying three distinct levels based on different actors' roles: macro (setting policy boundaries), meso (implementation of the policy framework), and micro (farmer actions). Second, this study develops an analytical framework to investigate barriers hindering AES environmental performance and their linkage to AES governance. The combined frameworks have been tested in a regional case study in the Hauts-de-France region. A list of 40 barriers is identified, spanning organizational, power dynamics, and financial issues. Barriers are not confined to farm or policy scale, distributing unevenly across governance levels, with different agencies across roles and actors in unlocking the AES performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.